📌 Key Takeaways
- Topic: Spherical Silica Powder: Specifications, Particle Sizes and How to Choose the Right Grade
- Keywords: silica powder supplier
- Published: 2026-11-20 14:04:53
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Why Is Silicon Dioxide a Covalent Network Solid? Structure and Properties Explained
- Silica in Cosmetics: Functions, Types and Safety
- Zhou, S. et al. Acid-redox bifunctional Fe/Al-AMS catalyst: Simultaneously oriented introducing Fe 2 O 3 in the channels and Al in the framework of AMS and its enhanced catalytic performance. Appl. Catal. A Gen. 575, 159-169 (2019). Post CAS Google Scholar
- Electronic Grade Silica: Purity Requirements, Specifications and Applications
- Silica for Chromatography: Particle Size, Pore Size and Grade Selection
- Guo, B. et al. A porphyrin‐based conjugated polymer for highly efficient in vitro and in vivo photothermal therapy. Tiny 12, 6243-6254 (2016). Post CAS PubMed Google Scholar
- Silica Polishing Slurry: How It Works, Particle Sizes and Applications
Silica for Wafer Polishing: Slurry Types, Particle Size and Performance
What is silica (SiO₂)?
wollastonite
What is the difference between fumed silica and precipitated silica?
silica oil absorption
What drives silica raw material prices?
BET surface area silica MSNs are gradually being developed as promising drug delivery carriers due to their brilliant biocompatibility, biodegradability, and greatly ordered pore structure. Owing to the great flexibility in tuning the surface properties of MSNs, specific surface functionalization modification of MSNs can achieve precise modulation of drug delivery behavior, thus to meet the application requirements. Currently, the most researched is the construction of stimuli-responsive MSNs-based drug delivery system (Fig. 6c ), i.e., when MSNs reach the lesion site, the release of drugs is controllably stimulated by specific internal or external components, thus achieving the improved drug utilization and staying away from drug leakage at non-lesion sites. 259, 272, 331 The most core step in this process is connecting some caps with stimulus-responsive properties onto the MSNs surface, which can be called gatekeepers, 119, 158 nanovalves, 332, 333 or others. Once the therapeutic drug is filled into the mesopore of MSNs, the pore entrances are blocked by the caps to prevent the drug from diffusing out. Under normal physiological conditions, the caps always keep the pores in a closed state, but when reaching to the lesion, the caps are separated under the stimulation of certain components, which in turn induces targeted on-demand release of drugs. These caps can be polymers, 334 metal/metal compound NPs, 170, 335 biomolecules, 336 etc. While exogenous stimuli such as light, ultrasound, magnetic field and electric field, endogenous stimuli such as temperature, pH, redox agents, and enzymes, can activate the caps. Several examples about the surface modification of MSNs and the corresponding stimuli-responsive plans are briefly clarified here.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.